The global human papillomavirus vaccine (HPV) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). There are more than 100 HPV, among which 14 are cancer-causing. According to the WHO, HVP 16 and 18 types are responsible for around 70% of cervical cancer and pre-cancerous cervical lesions. The rising incidences […]
